Service Hotline: 400-826- 0806

News center


Ruikang Medicine won the "Top Ten Most Growing Listed Companies in China Small and Medium Enterpris

Date: 2018-08-23
Views: 42

On August 12th, the “New Era New Dynamic Energy Value – The 12th China Listed Company Value Forum and Awarding Ceremony” hosted by the Securities Times was held in Qingdao. The “Twelfth China Listed Company Value” was announced at the meeting. Selected "list of awards." TTGG invested in the company - Ruikang Pharmaceutical won the "Top Ten Most Growing Listed Companies in China's Small and Medium Enterprises Boards" with its outstanding comprehensive strength.

The value of Chinese listed companies is a value discovery activity for listed companies in China's capital market and with brand influence. Based on the listed company's profitability, growth, investment income, market and brand influence, the company has made a comprehensive evaluation of its financial performance. A listed company with a high level of governance, an excellent management team, and a value standard in terms of brand strategy.

Ruikang Pharmaceutical is committed to building a direct sales network directly to medical institutions and retail channels, from the initial regional drug distribution company to a comprehensive medical service provider that sells drugs and machinery across the country, becoming the national pharmaceutical and medical device circulation industry. Leading enterprises, the sales network covers 31 provinces and cities nationwide.


 Since the company was listed in 2011, the compound revenue growth rate has reached 40%. Since the listing, the compound profit growth rate of the parent company's net profit has exceeded 50%. In 2017, the company realized operating income of 23.3 billion yuan, net profit attributable to shareholders of listed companies was 1 billion yuan, a year-on-year increase of 70%, and taxes paid over 1 billion yuan. In the top 100 national pharmaceutical business rankings announced by the Ministry of Commerce, the company was established in 2010. The 38th place rose to the 10th place in 2017 (ranked by main business income), ranking first in the pharmaceutical commercial sales volume in Shandong Province. The company ranked 381th in the 2017 Fortune China 500 list.


News / Related news More
2021 - 01 - 18
On January 18, 2021, Tianneng Battery Group Co., Ltd. (hereinafter referred to as 'Tianneng shares', stock code: 688819), an investment company invested by Paradise Silicon Valley Holdings' parent company, Silicon Valley Paradise, officially landed on the Science and Technology Innovation Board.Tianneng Co., Ltd. was established in 2003. It is a green power battery business for electri...
2017 - 11 - 30
CAI Gangqing, president and deputy secretary of the Party Committee of Anji Industrial Investment Development Group (IIDG) paid a visit to TTGG with 5 colleagues on the afternoon of 30th November. ZOU Jin, general manager and deputy secretary of the Party Committee of IIDG, FANG Jun, vice-general manager, and other department heads of IIDG attended the discussion. Our managing partner ZHANG Y...
2017 - 11 - 28
Zvi Heifetz, Israeli Ambassador to China, paid a visit to TTGG along with his wife on the evening of 28th November 2017. They were greeted by TTGG’s president YU Baohong. ZHANG Yu and GUO Feng, managing partners of TTGG, LI Xiang, general-manager of Investment Management Department, and other department heads also took part in the meeting.After greeting, YU briefly introduced TTGG’s hist...
2017 - 08 - 14
With the accelerating rhythm of the society, more and more white-collars are feeling stressed under modern work environments. In fact, such stress primarily results from the target-oriented time management. The key factors facilitating their abilities to improve time management efficiency and effectiveness are: how to find the causes of inefficiency, how to distinguish between the important things...
Copyright © 2016 - 2019 Zhejiang Paradise Silicon Valley Asset Management Group Co., Ltd










  • 400-826-0806